ClinicalTrials.gg
CompletedNCT03686956Updated Aug 17, 2020

Repair by Rehabilitation of Pelvic Floor Lesions After Vaginal Delivery Identified by Transperineal Ultrasound 3/4 D

An interventional study of Physiotherapy treatment in Pelvic Floor Disorders, Obstetric Trauma and Physical Disorder, sponsored by Hospital Universitario de Valme. Completed at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-08-17.

Sponsored by Hospital Universitario de Valme · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Pelvic Floor Disorders with a site in Spain — 9 open to participants now, 10 under way, none of them phase 3. Pelvic Floor Disorders · Spain.

Enrollment
8th of 26
92 · median 68
Started
2018
with 2 others
No phase
25 of 29
7 open now
Registered
4th of 29
by date
Lead sponsor
3 of 29
Hospital Universitario de Valme

Among the 29 studies in Pelvic Floor Disorders with a site in Spain, this one is the 8th largest by enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2018, is one of 25 with no phase, and was the 4th registered.

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

Browse Pelvic Floor Disorders studies →

Open to participants now

9 of the 29 studies in Pelvic Floor Disorders with a site in Spain are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Pelvic Floor Disorders with a site in Spain, or all of them as a file.
02

Study summary

SUMMARY: (Objective, design, scope of the study, subjects of study, instrumentation, results, conclusions)

Objectives: To evaluate if the physiotherapy treatment in pelvic floor dysfunctions, identified by transperineal ultrasound 3 / 4D, in postpartum improve the tone and functionality of pelvic floor.

Design: Post-authorization, prospective, longitudinal randomized intervention study

Scope: Full-term deliveries at the University Hospital. Subjects of study: Full-term primiparous and full-term pregnancies with pelvic floor lesion, identified by transperineal ultrasound 3 / 4D, which are randomized between the physiotherapy treatment of pelvic floor and the non-work.

Variables: Primary variable: Assess the improvement in contractility / tone, evaluation by manometry and assess the anatomical improvement of the area of ?? the genital hiatus, stay by transperineal ultrasound 3 / 4D. Secondary variables: Identify the levator ani muscle injury rate, estimate the sonographic changes in the levator ani muscle through rehabilitation. Analyze the improvement of the symptoms associated with the public organic prolapse and evaluate the improvement of the quality of life.

Data analysis: To detect a difference of 10% in the reduction of the size of the index between the study groups (not intervened / intervened) after 6 months of intervention, standard deviation 10%, Error-alpha 5%, Error- beta 10% (P90%) we need 23 women in each group. Assuming a loss of 10% in the follow-up, the final size would be 52 women, 26 per group.

03

Conditions studied

  • Pelvic Floor Disorders
  • Obstetric Trauma
  • Physical Disorder
  • Physical Activity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Vaginal delivery
  • Cephalic presentation
  • Primiparity
  • At term gestation (37-42 weeks)
  • No prior pelvic floor corrective surgery
  • Written

Exclusion criteria

Exclusion Criteria:

  • Pregnancies with severe maternal or fetal pathology
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
92 participants (actual)

Study arms

  • Experimental
    Experimental group

    The therapy lasted two months, at a rate of two sessions per week, with a duration of 45 minutes per session. The program consisted of pelvic floor exercises assisted by manometric biofeedback, which were performed in supine position for 20 minutes. In addition, active lumbopelvic stabilization exercises, including the contraction of pelvic floor muscles was performed in supine, plank and quadruped position. Together with the treatment at the clinic, patients were asked to perform a series of exercises at home, consisting in: 8-12 sustained contractions of 6 seconds, with a subsequent rest period of double the work-time, followed by 3-5 fast contractions of 2 seconds with maximum intensity, resting double the work-time. Domiciliary exercises were performed in supine, siting and standing position.

    Other: Physiotherapy treatment

  • No intervention
    Control group

    The control group received an information brochure with recommendations, including the same program of pelvic floor exercises taught to the patients in the experimental group, but without carrying out any kind of supervision by the physiotherapist.

Interventions

  • OtherPhysiotherapy treatment

    Physiotherapy treatment consisted of pelvic floor exercises assisted by manometric biofeedback. In addition, active lumbopelvic stabilization exercises, including the contraction of pelvic floor muscles was performed in supine, plank and quadruped position.

06

What researchers measure

Primary outcomes

  1. To evaluate the changes in pressure in the contractility evaluated by manometry (mm Hg)

    To evaluate the changes in pressure in the contractility evaluated by manometry (mm Hg), of the medical floor produced by the treatment of postpartum physiotherapy of the pelvic floor

    Time frame: 6 months after randomisation

  2. Changes in muscle thickness (millimeters) of the levator ani muscle

    Changes in muscle thickness (millimeters) of the levator ani muscle, measured with transperineal ultrasound 3-4D

    Time frame: 6 months after randomisation

07

Study locations

1 site
  • Hospital Nuestra Señora de Valme
    Sevilla, 41014, Spain
08

References and documents

Publications

  • Sainz-Bueno JA, Bonomi MJ, Suarez-Serrano C, Medrano-Sanchez EM, Armijo A, Fernandez-Palacin A, Garcia-Mejido JA. Quantification of 3/4D ultrasound pelvic floor changes induced by postpartum muscle training in patients with levator ani muscle avulsion: a parallel randomized controlled trial. Quant Imaging Med Surg. 2022 Apr;12(4):2213-2223. doi: 10.21037/qims-21-877. PubMed 35371949 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2018 to primary completion in Mar 2019, 7 months.

Of 100 non-industry interventional studies with no phase under Pelvic Floor Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's 7 months is below that.

Counting every sponsor, half of 106 studies reached it within 17 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2018
First posted
Sep 27, 2018
StartActual
Aug 1, 2018
Primary completionActual
Mar 1, 2019
CompletionActual
Jun 1, 2019
Last update
Aug 17, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03686956
Lead sponsor
Hospital Universitario de Valme
Responsible party
José Antonio García Mejido (Dr., Hospital Universitario de Valme) — Principal investigator
First posted
Sep 27, 2018
Start date
Aug 1, 2018
Primary completion
Mar 1, 2019
Completion
Jun 1, 2019
Last update
Aug 17, 2020

Study contacts

José Antonio García Mejido
principal investigator · Hospital Universitario de Valme

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion